Stocks and Investing
Stocks and Investing
Tue, April 12, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sean Dodge Maintained (TDOC) at Buy with Decreased Target to $120 on, Apr 12th, 2022
Sean Dodge of RBC Capital, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $215 to $120 on, Apr 12th, 2022.
Sean has made no other calls on TDOC in the last 4 months.
There are 16 other peers that have a rating on TDOC. Out of the 16 peers that are also analyzing TDOC, 6 agree with Sean's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $72 on, Tuesday, March 8th, 2022
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $78 on, Thursday, February 24th, 2022
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $74 on, Wednesday, February 23rd, 2022
- Matt Hewitt of "Craig-Hallum" Maintained at Hold with Decreased Target to $67 on, Wednesday, February 23rd, 2022
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $77 on, Wednesday, February 23rd, 2022
- Glen Santangelo of "Jefferies" Maintained at Hold with Decreased Target to $82 on, Monday, February 7th, 2022
These are the ratings of the 10 analyists that currently disagree with Sean
- Sandy Draper of "Guggenheim" Initiated at Strong Buy and Held Target at $96 on, Thursday, April 7th, 2022
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $104 on, Tuesday, March 8th, 2022
- John Eade of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $95 on, Thursday, March 3rd, 2022
- Jailendra Singh of "Credit Suisse" Maintained at Buy with Decreased Target to $114 on, Friday, February 25th, 2022
- Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $100 on, Wednesday, February 23rd, 2022
- Lisa Gill of "JP Morgan" Maintained at Buy with Decreased Target to $125 on, Wednesday, February 23rd, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $130 on, Wednesday, February 23rd, 2022
- Ryan MacDonald of "Needham" Maintained at Strong Buy with Decreased Target to $100 on, Wednesday, February 23rd, 2022
- Stephanie Davis Demko of "SVB Leerink" Maintained at Buy with Decreased Target to $161 on, Wednesday, February 23rd, 2022
- Cindy Motz of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Friday, February 11th, 2022
Contributing Sources